Know Cancer

or
forgot password

The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma: A Multicenter, Prospective, Randomized Trial


N/A
18 Years
50 Years
Open (Enrolling)
Female
Endometrial Neoplasms

Thank you

Trial Information

The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma: A Multicenter, Prospective, Randomized Trial


Inclusion Criteria:



- FIGO stage: ⅠA, endometrial carcinoma;

- Female, Chinese women;

- premenopausal women;

- ≤ 50 years old;

- Pathological diagnosis by curettage/hysteroscopy : G1

- No prior treatment;

- Provide written informed consent.

Exclusion Criteria:

- The suspicious metastasis of ovarian;

- Family history of ovarian cancer;

- Suffering from other malignancies;

- Concurrently participating in other clinical trials;

- Unable or unwilling to sign informed consents;

- Unable or unwilling to abide by protocol.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Disease-free survival (DFS)

Outcome Time Frame:

3-year DFS

Safety Issue:

No

Principal Investigator

Beihua Kong, MD, PhD

Investigator Role:

Study Chair

Investigator Affiliation:

Shandong University

Authority:

China: Ministry of Health

Study ID:

2012-GYN/EC-02

NCT ID:

NCT01820884

Start Date:

November 2012

Completion Date:

December 2017

Related Keywords:

  • Endometrial Neoplasms
  • Neoplasms
  • Carcinoma
  • Endometrial Neoplasms
  • Adenoma

Name

Location